Avance Clinical to attend BIO Asia–Taiwan 2026 as it expands China push

The Australian-headquartered CRO said rising demand for globally aligned, multi-regional clinical development is driving deeper investment across Asia, including new business development roles in Shanghai and Beijing.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.